Cystatin C in cerebrospinal fluid is not a diagnostic test for pain in humans.

PubWeight™: 1.44‹?› | Rank: Top 5%

🔗 View Article (PMID 14736582)

Published in Pain on February 01, 2004

Authors

James C Eisenach1, John A Thomas, Richard L Rauck, Regina Curry, Xinhui Li

Author Affiliations

1: Department of Anesthesiology and Center for the Study of Pharmacologic Plasticity in the Presence of Pain, Wake Forest University School of Medicine, Medical Center Boulevard, Winston-Salem, NC 27157-1009, USA. eisenach@wfubmc.edu

Associated clinical trials:

Mindfulness and Chronic Low Back Pain | NCT03354585

Articles by these authors

Randomized clinical trial of an implantable drug delivery system compared with comprehensive medical management for refractory cancer pain: impact on pain, drug-related toxicity, and survival. J Clin Oncol (2002) 3.25

Intrathecal ketorolac does not improve acute or chronic pain after hip arthroplasty: a randomized controlled trial. J Anesth (2014) 1.38

Intrathecal, but not intravenous adenosine reduces allodynia in patients with neuropathic pain. Pain (2003) 1.35

Effects of intrathecal ketorolac on human experimental pain. Anesthesiology (2010) 1.31

Gabapentin activates spinal noradrenergic activity in rats and humans and reduces hypersensitivity after surgery. Anesthesiology (2007) 1.27

Intravenous remifentanil produces withdrawal hyperalgesia in volunteers with capsaicin-induced hyperalgesia. Anesth Analg (2003) 1.24

Personal care products and endocrine disruption: A critical review of the literature. Crit Rev Toxicol (2010) 1.22

Role of spinal cyclooxygenase in human postoperative and chronic pain. Anesthesiology (2010) 1.20

Polyanalgesic Consensus Conference 2003: an update on the management of pain by intraspinal drug delivery-- report of an expert panel. J Pain Symptom Manage (2004) 1.10

Aspartame: review of safety. Regul Toxicol Pharmacol (2002) 1.08

Relation of residency selection factors to subsequent orthopaedic in-training examination performance. South Med J (2005) 1.08

Analysis of integrons in clinical isolates of Escherichia coli in China during the last six years. FEMS Microbiol Lett (2006) 1.06

Analgesia from a peripherally active kappa-opioid receptor agonist in patients with chronic pancreatitis. Pain (2003) 1.05

Phase I safety assessment of intrathecal ketorolac. Pain (2002) 1.05

An updated interdisciplinary clinical pathway for CRPS: report of an expert panel. Pain Pract (2002) 1.04

Comprehensive consensus based guidelines on intrathecal drug delivery systems in the treatment of pain caused by cancer pain. Pain Physician (2011) 1.02

An injectable thiol-acrylate poly(ethylene glycol) hydrogel for sustained release of methylprednisolone sodium succinate. Biomaterials (2010) 1.00

Cephalad movement of morphine and fentanyl in humans after intrathecal injection. Anesthesiology (2003) 0.97

NTP-CERHR expert panel report on the reproductive and developmental toxicity of genistein. Birth Defects Res B Dev Reprod Toxicol (2006) 0.95

Ropivacaine 0.075% and bupivacaine 0.075% with fentanyl 2 microg/mL are equivalent for labor epidural analgesia. Anesth Analg (2002) 0.95

Small interfering RNA targeted to secretory clusterin blocks tumor growth, motility, and invasion in breast cancer. Acta Biochim Biophys Sin (Shanghai) (2012) 0.95

Dose response of intrathecal adenosine in experimental pain and allodynia. Anesthesiology (2002) 0.93

Long-term safety, tolerability, and efficacy of OROS hydromorphone in patients with chronic pain. J Opioid Manag (2009) 0.92

alpha2-Adrenoceptor activation by clonidine enhances stimulation-evoked acetylcholine release from spinal cord tissue after nerve ligation in rats. Anesthesiology (2005) 0.90

NTP-CERHR expert panel report on the reproductive and developmental toxicity of soy formula. Birth Defects Res B Dev Reprod Toxicol (2006) 0.90

Sudden cardiac death in children and adolescents: introduction and overview. Pediatr Clin North Am (2004) 0.88

Assessment of cadmium (Cd) concentration in arable soil in China. Environ Sci Pollut Res Int (2014) 0.88

Preliminary efficacy assessment of intrathecal injection of an American formulation of adenosine in humans. Anesthesiology (2002) 0.87

Peripheral nerve injury alters the alpha2 adrenoceptor subtype activated by clonidine for analgesia. Anesthesiology (2002) 0.86

Intrathecal but not intravenous opioids release adenosine from the spinal cord. J Pain (2004) 0.85

Inactivation of human norovirus in contaminated oysters and clams by high hydrostatic pressure. Appl Environ Microbiol (2014) 0.84

Ziconotide combination intrathecal therapy: rationale and evidence. Clin J Pain (2010) 0.83

Intrathecal morphine reduces allodynia after peripheral nerve injury in rats via activation of a spinal A1 adenosine receptor. Anesthesiology (2005) 0.82

Inhibition of the mitochondrial permeability transition by aldehydes. Biochem Biophys Res Commun (2002) 0.82

Spinal adrenergic and cholinergic receptor interactions activated by clonidine in postincisional pain. Anesthesiology (2003) 0.80

Impact of implant design on femoral head hemiresurfacing arthroplasty. Clin Orthop Relat Res (2004) 0.80

Intrathecal adenosine following spinal nerve ligation in rat: short residence time in cerebrospinal fluid and no change in A(1) receptor binding. Anesthesiology (2002) 0.80

New array of aacA4-catB3-dfrA1 gene cassettes and a noncoding cassette from a class-1-integron-positive clinical strain of Pseudomonas aeruginosa. Antimicrob Agents Chemother (2006) 0.80

Allosteric modulation of adenosine A1 receptor coupling to G-proteins in brain. J Neurochem (2005) 0.80

Spinal adenosine receptor activation reduces hypersensitivity after surgery by a different mechanism than after nerve injury. Anesthesiology (2004) 0.79

Spinal norepinephrine release from nitric oxide species is not increased following peripheral nerve injury in rats. Brain Res (2002) 0.78

Phase I safety assessment of intrathecal injection of an American formulation of adenosine in humans. Anesthesiology (2002) 0.78

Marek's disease virus phosphorylated polypeptide pp38 alters transcription rates of mitochondrial electron transport and oxidative phosphorylation genes. Virus Genes (2009) 0.77

Antibiotic-resistant bacteria associated with retail aquaculture products from Guangzhou, China. J Food Prot (2013) 0.77

Considerations and methodology for trialing ziconotide. Pain Physician (2010) 0.77

Intraspinal adenosine induces spinal cord norepinephrine release in spinal nerve-ligated rats but not in normal or sham controls. Anesthesiology (2003) 0.77

A randomized controlled comparison between combined spinal-epidural and single-shot spinal techniques in morbidly obese parturients undergoing cesarean delivery: time for initiation of anesthesia. Anesth Analg (2014) 0.76

Phase 1 safety assessment of intrathecal oxytocin. Anesthesiology (2015) 0.76

Correction: Temporal Patterns of Larval Fish Occurrence in a Large Subtropical River. PLoS One (2016) 0.75

An Open-Label, Multicenter Study of the Safety and Efficacy of Intrathecal Ziconotide for Severe Chronic Pain When Delivered via an External Pump. Neuromodulation (2008) 0.75

First specifically designed comparative outcome study? Re: Cheng et al, Clin J Pain 2012. Clin J Pain (2014) 0.75

Enhanced PCR amplification of GC-rich DNA templates by gold nanoparticles. ACS Appl Mater Interfaces (2013) 0.75

Successful dose finding with sublingual fentanyl tablet: combined results from 2 open-label titration studies. Pain Pract (2012) 0.75

"Black Box" warning labels and drug withdrawals. Toxicol Appl Pharmacol (2002) 0.75

[Synthesis and evaluation of high performance gel filtration chromatography packing of KH-s-GFC300]. Se Pu (2005) 0.75

[Preparation of porous silica microspheres with high porosity using base-dissolving method]. Se Pu (2005) 0.75

Intrathecal ketorolac reverses hypersensitivity following acute fentanyl exposure. Anesthesiology (2002) 0.75

The delayed appearance of neurological signs in intrathecal granuloma warrants imaging surveillance: a case series and review of the literature. Pain Pract (2012) 0.75